5 Recruiting Trials

Clinical Trials for Parkinson's in District of Columbia

5 clinical trials for Parkinson's are currently recruiting participants at study sites in District of Columbia. Study-related care is provided at no cost.

Showing 5 of 5 recruiting Parkinson's trials in District of Columbia

Recruiting
Social & QoL Behaviors in Parkinson's Disease
N/A Washington D.C., District of Columbia NCT06385184
Recruiting

Parkinson's clinical trials in District of Columbia: common questions

How many Parkinson's clinical trials are recruiting in District of Columbia?
TrialFinder currently lists 5 recruiting Parkinson's clinical trials with study sites in District of Columbia. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are Parkinson's clinical trials located in District of Columbia?
Study sites for the Parkinson's trials listed on this page include Washington D.C.. Each trial page lists every participating site with contact details, so you can find the location closest to you.
Do I need insurance to join a Parkinson's clinical trial in District of Columbia?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many Parkinson's trials in District of Columbia also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a Parkinson's clinical trial in District of Columbia?
Each study sets its own criteria based on age, Parkinson's diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.

Check Your Eligibility

Create a free profile and our AI will match you to Parkinson's trials near you in District of Columbia.

Get Matched — Free
No insurance required

Parkinson's disease trials test dopamine-replacement therapies, deep brain stimulation, gene therapies, and neuroprotective compounds to slow disease progression.

All Parkinson's trials →